Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.
Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.
Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
Symposium Chairs: Pieter Goeminne (Bornem, Belgium), Tobias Welte (Hannover, Germany)
Aims: To review the results of the latest bronchiectasis clinical trials, compare the pros and cons of oral and inhaled antibiotic therapies in bronchiectasis, describe the emerging scientific techniques that are used to study the airway microbiome and monitor airway inflammation in bronchiectasis, review the evidence for physiotherapy management and emerging airway clearance devices and therapies and describe the activities of the European bronchiectasis network and the opportunities to participate.
Target audience: This session will be of interest to clinicians, microbiologists, physiotherapists, specialist nurses, and scientists who are interested in non-cystic fibrosis bronchiectasis.